References: |
1. |
Naoi, M., Maruyama, W., Dostert, P., Kohda, K. and Kaiya, T. A novel enzyme enantio-selectively synthesizes (R)-salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl-(R)-salsolinol. Neurosci. Lett. 212 (1996) 183–186. [DOI] [PMID: 8843103] |
2. |
Naoi, M., Maruyama, W., Takahashi, T., Akao, Y. and Nakagawa, Y. Involvement of endogenous N-methyl-(R)-salsolinol in Parkinson’s disease: induction of apoptosis and protection by (–)deprenyl. J. Neural Transm. Suppl. (2000) 111–121. [DOI] [PMID: 11128601] |
3. |
Chen, X., Zheng, X., Ali, S., Guo, M., Zhong, R., Chen, Z., Zhang, Y., Qing, H. and Deng, Y. Isolation and sequencing of salsolinol synthase, an enzyme catalyzing salsolinol biosynthesis. ACS Chem Neurosci 9 (2018) 1388–1398. [DOI] [PMID: 29602279] |
4. |
Xiong, Q., Zheng, X., Wang, J., Chen, Z., Deng, Y., Zhong, R., Wang, J. and Chen, X. Sal synthase induced cytotoxicity of PC12 cells through production of the dopamine metabolites salsolinol and N-methyl-salsolinol. J Integr Neurosci 21:71 (2022). [DOI] [PMID: 35364659] |
|